4 completed, 1 active not recruiting. 2 Phase 3, 2 Phase 4, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Completed 1 |
| Phase 4 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
Follow USRC Kidney Research: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Feasibility Study of Dialysis Clinic Semi-Autonomous Ultrasound Scanning Using the Vexev Ultrasound Imaging System for Arteriovenous Fistula Mapping Examinations. The CANSCAN Trial. Robotic Tomographic ultrasound imaging of the arm vasculature. - Feasibility Assessment of the VxWave Device for Vascular Access Imaging | Not applicable | Completed | Vexev Pty Ltd | 120 | 2024-11-20 | 2025-05-18 |
| Vafseo Outcomes In-Center Experience Vadadustat, Erythropoiesis Stimulating Agent - Anemia of Chronic Kidney Disease | Phase 3 | Active not recruiting | USRC Kidney Research | 2200 | 2024-11-20 | 2026-03-10 |
| A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease Daprodustat - Anemia, Renal Insufficiency, Chronic | Phase 4 | Completed | USRC Kidney Research | 161 | 2023-07-01 | 2024-05-24 |
| Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease Ferric Citrate 1 GM Oral Tablet [AURYXIA], Placebo - Anemia, Iron Deficiency, Hyperphosphatemia | Phase 3 | Completed | USRC Kidney Research | 289 | 2022-03-30 | 2025-08-29 |
| Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants Ferric Citrate 1 gram Oral Tablet, Standard of care phosphate-lowering therapy - Hyperphosphatemia, Anemia, Iron Deficiency | Phase 4 | Completed | USRC Kidney Research | 214 | 2021-06-29 | 2022-11-07 |
Anemia, Iron-Deficiency (2) · Hyperphosphatemia (2) · Renal Insufficiency, Chronic (2) · Anemia (1) · Disease Progression (1) · Renal Insufficiency (1)
ferric citrate (2) · Darbepoetin alfa (1) · Epoetin Alfa (1) · GSK1278863 (1) · Hematinics (1) · continuous erythropoietin receptor activator (1) · vadadustat (1)
United States (5)
Geoff Block, MD (1) · Geoffrey Block, MD (1)